You searched for precision medicine - Page 24 of 65

Best in Biotech 22 May 2023

Five recent advancements in arthritis research over the past year

…channel could curb inflammation, making the pathway a therapeutic target to be reckoned with. Could regenerative medicine cure arthritis? Growing research in regenerative medicine has proven its scope time and…

May 22, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 28 Aug 2024

GLP-1 shortage: Can biotech companies keep up with rising demand?

…committed more than $18 billion to build, expand and acquire facilities in the U.S. and Europe. These facilities and investments will address growth from potential new medicines to treat diabetes…

August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

Inotrem Septic Shock Blood Infection Header

News and Trends 2 Oct 2018

Septic Shock Drug Shows Promise for Personalized Medicine

Septic shock may no longer be as shocking in the future, as a Phase IIa trial brings hope for a personalized immunomodulatory treatment from the French biotech Inotrem. In sepsis,…

October 2, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 20 Jun 2016

GMO Tobacco could Produce cheaper Medicine for Malaria

Researchers from the Max Planck Institute of Molecular Plant Physiology in Potsdam have altered tobacco to produce large yields of artemisinin – the most effective treatment for malaria but still…

June 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

Best in Biotech 5 Sep 2023

Five recent advancements in ovarian cancer research over the past year

…a TLS to have more or less TLS function, and that will help us identify potential targets for therapy,” said Lu. The study was published in Cell Reports Medicine, and…

September 5, 2023 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 30 Oct 2015

Purple GMO Tomatoes are Growing Medicines in the UK

Meet the purple tomatoes which produce as much Revervesterol in a single fruit as 50 bottles of wine, and as much anti-breast cancer chemical as 2.5Kg of Tofu! The John…

October 30, 2015 - 2 minutesmins - By Dani Bancroft

More News! 9 Nov 2022

Sensorium closes $30M deal to advance drug discovery engine

…challenges in central nervous system drug development by tapping into the vast chemical space of psychoactive molecules to develop novel medicines that address the global crisis. Beginning with evidence of…

November 9, 2022 - 3 minutesmins - By Liza Laws

News and Trends 15 Mar 2016

French Nanomedicine Biotech Gets €21M to Kill Cancer with ‘Beam Rays’

Nanobiotix (France) has had a successful private placement in, raising €21.3M to advance the clinical development of its localised radiotherapy for Cancer. Located in Paris’ superbiocluster, Nanobiotix wants to change…

March 15, 2016 - 2 minutesmins - By Denise Neves Gameiro

In Depth 26 Jul 2023

Antibody drug conjugates: BiVictriX drives a new era in cancer medicine

The first-ever antibody-drug conjugate (ADC) to be approved, gemtuzumab ozogamicin, raised hope for a new class of drugs to treat cancer. But the drug was then withdrawn following a black…

July 26, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 28 Jul 2021

Microbiome Medicines Could Power Up CAR-T Cell Therapies

The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings that gut bacteria metabolites may help CAR-T cell therapies penetrate and kill solid tumors. A…

July 28, 2021 - 5 minutesmins - By Mark Zipkin

News and Trends 18 Nov 2022

AstraZeneca and Daiichi Sankyo’s Enhertu recommended for approval

…Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on results from the DESTINY-Gastric02 and the DESTINY-Gastric01 phase 2 trials. Updated results…

November 18, 2022 - 3 minutesmins - By Liza Laws

News and Trends 18 Mar 2016

Roche signs a €900M deal with an Immunotherapy Biotech in Boston

…be aiming at over €850M ($965M) in milestones and licenses. A true billion dollar deal. The team of Blueprint Medicines (Source: Blueprint Medicines) So, what did catch Roche’s eyes (and…

March 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: precision medicine

Five recent advancements in arthritis research over the past year

GLP-1 shortage: Can biotech companies keep up with rising demand?

Septic Shock Drug Shows Promise for Personalized Medicine

GMO Tobacco could Produce cheaper Medicine for Malaria

Five recent advancements in ovarian cancer research over the past year

Purple GMO Tomatoes are Growing Medicines in the UK

Sensorium closes $30M deal to advance drug discovery engine

French Nanomedicine Biotech Gets €21M to Kill Cancer with ‘Beam Rays’

Antibody drug conjugates: BiVictriX drives a new era in cancer medicine

Microbiome Medicines Could Power Up CAR-T Cell Therapies

AstraZeneca and Daiichi Sankyo’s Enhertu recommended for approval

Roche signs a €900M deal with an Immunotherapy Biotech in Boston

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!